Metabolic Modeling Identifies a Novel Molecular Type of Glioblastoma Associated with Good Prognosis

Glioblastoma (GBM) is one of the most aggressive forms of cancer. Although IDH1 mutation indicates a good prognosis and a potential target for treatment, most GBMs are IDH1 wild-type. Identifying additional molecular markers would help to generate personalized therapies and improve patient outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Qiu, Yang, Hua, Kong, Qing-Peng, Li, Gong-Hua, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964559/
https://www.ncbi.nlm.nih.gov/pubmed/36837790
http://dx.doi.org/10.3390/metabo13020172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964559/
https://www.ncbi.nlm.nih.gov/pubmed/36837790
http://dx.doi.org/10.3390/metabo13020172

Ejemplares similares